Core Viewpoint - The company Jianxin Superconductor (688805.SH) has initiated its subscription with an issue price of 18.58 yuan per share and a price-to-earnings ratio of 61.97 times, focusing on the research, production, and sales of core components for MRI equipment, which account for approximately 50% of the cost of MRI devices [1]. Group 1: Company Overview - The company specializes in the research, production, and sales of core components for medical MRI equipment, including superconducting magnets, permanent magnets, and gradient coils [1]. - The company has achieved breakthroughs in core technologies for superconducting magnets, permanent magnets, and gradient coils, ensuring the independence and controllability of core components in the domestic MRI industry [2]. Group 2: Product Development and Market Position - The company has developed a comprehensive product matrix in the superconducting field, including 1.5T and 3.0T zero-evaporation superconducting magnets, becoming the world's leading independent supplier of superconducting magnets [2]. - The company has closed a 20-year technology gap with international giants in zero-evaporation superconducting technology and has broken the long-standing monopoly of European, American, and Japanese manufacturers in the 1.5T product field since 2015 [2]. Group 3: Technological Advancements - The company has transitioned from a follower to a leader in the next-generation helium-free superconducting technology, achieving a fully helium-free superconducting magnet and being recognized as the "international first set of equipment" by the Zhejiang Provincial Economic and Information Technology Department in 2021 [3]. - The company is the largest supplier of MRI permanent magnets globally, providing high-quality products that are economically viable and suitable for grassroots medical systems [3]. Group 4: Financial Performance - The company reported revenues of approximately 359 million yuan, 451 million yuan, 425 million yuan, and 252 million yuan for the years 2022, 2023, 2024, and the first half of 2025, respectively, with net profits of 34.63 million yuan, 48.73 million yuan, 55.78 million yuan, and 31.92 million yuan during the same periods [4]. - As of June 30, 2025, the total assets of the company were approximately 688.99 million yuan, with a debt-to-asset ratio of 29.22% [5].

Core Viewpoint - Magnetic resonance technology is a key tool in modern scientific research, with significant applications across various fields, including chemistry, physics, biology, medicine, materials science, food safety, and earth sciences. The continuous emergence of scientific challenges and deepening application demands have led to breakthroughs in core technologies such as Nuclear Magnetic Resonance (NMR), Electron Paramagnetic Resonance (EPR/ESR), and Magnetic Resonance Imaging (MRI), driving rapid development in the magnetic resonance field. China has made notable progress in the research and application of magnetic resonance technology, with domestic manufacturers focusing on enhancing core competencies and gradually closing the gap with international standards [2][3]. Event Overview - The "9th iConference on Magnetic Resonance (iCMR 2025)" will be jointly hosted by Instrument Information Network, the Magnetic Resonance Branch of the China Association for Analysis and Testing, Beijing Spectroscopy Society, and the Journal of Spectroscopy. The conference aims to foster innovation, academic exchange, and collaboration between academia and industry in the magnetic resonance field. It will provide a platform for experts, scholars, and young researchers to share research findings and access cutting-edge information, with content archived for future reference [3][5]. Conference Details - **Date**: November 4-5, 2025 - **Organizers**: Instrument Information Network, Magnetic Resonance Branch of the China Association for Analysis and Testing, Beijing Spectroscopy Society, Journal of Spectroscopy [5]. Conference Agenda Highlights - **November 4**: - Morning sessions on new technologies and applications in magnetic resonance, featuring presentations from experts such as: - Chen Wei on in-situ NMR research on polymer deformation mechanisms - Xu Jun on solid-state NMR studies of rare earth materials - Zhao Xinxing on advancements in quantum magnetic resonance technology [6][7]. - **November 5**: - Sessions on paramagnetic and low-field NMR technologies, including discussions on: - Advances in downhole NMR technology by Liao Guangzhi - EPR spectroscopy studies on protein structures by Yang Yin [7][8]. Roundtable Discussion - A roundtable discussion titled "The Right Time for Domestic Magnetic Resonance Technology Development" will feature prominent figures in the field, including: - Yang Haijun from Tsinghua University - Fu Hui from Peking University - Yang Peiqiang from Suzhou Newmai Analysis Instrument Co., Ltd. - He Yu from Guoyi Quantum Technology (Hefei) Co., Ltd. [8].